237 related articles for article (PubMed ID: 20564330)
1. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
Yoshikawa M; Hishikawa K; Marumo T; Fujita T
J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes.
Pan X; Wang X; Lei W; Min L; Yang Y; Wang X; Song J
Hepatology; 2009 Nov; 50(5):1577-87. PubMed ID: 19821529
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.
Xie L; Santhoshkumar P; Reneker LW; Sharma KK
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4731-40. PubMed ID: 24994865
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition.
Lei W; Zhang K; Pan X; Hu Y; Wang D; Yuan X; Shu G; Song J
Int J Biochem Cell Biol; 2010 Sep; 42(9):1489-97. PubMed ID: 20580679
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis.
Bi WR; Yang CQ; Shi Q
Hepatogastroenterology; 2012 Sep; 59(118):1960-3. PubMed ID: 22369740
[TBL] [Abstract][Full Text] [Related]
11. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.
Choi SY; Kee HJ; Kurz T; Hansen FK; Ryu Y; Kim GR; Lin MQ; Jin L; Piao ZH; Jeong MH
J Cell Mol Med; 2016 Dec; 20(12):2289-2298. PubMed ID: 27420561
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
Zhang A; Wang MH; Dong Z; Yang T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1323-31. PubMed ID: 16868306
[TBL] [Abstract][Full Text] [Related]
13. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
Park IH; Kang JH; Shin JM; Lee HM
PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition.
Hosper NA; van den Berg PP; de Rond S; Popa ER; Wilmer MJ; Masereeuw R; Bank RA
Exp Cell Res; 2013 Nov; 319(19):3000-9. PubMed ID: 23906925
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression.
Wang JP; Wen MH; Chen YT; Lee HH; Chiang ER; Lee YT; Liu CL; Chen TH; Hung SC
Differentiation; 2011 Feb; 81(2):119-26. PubMed ID: 21074928
[TBL] [Abstract][Full Text] [Related]
16. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
[TBL] [Abstract][Full Text] [Related]
17. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
19. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy.
Chen YT; Wei JD; Wang JP; Lee HH; Chiang ER; Lai HC; Chen LL; Lee YT; Tsai CC; Liu CL; Hung SC
Spine (Phila Pa 1976); 2011 Aug; 36(18):E1193-200. PubMed ID: 21343850
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
